Microbial Metabolite Dysbiosis and Colorectal Cancer

키워드

참고문헌 (152)

1. Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 68, pp.394~424 (2018)
2. Moghimi-Dehkordi B, "An overview of colorectal cancer survival rates and prognosis in Asia", World J Gastrointest Oncol, 4, pp.71~75 (2012)
3. Arnold M, "Global patterns and trends in colorectal cancer incidence and mortality", Gut, 66, pp.683~691 (2017)
4. Ocvirk S, "Influence of bile acids on colorectal cancer risk : potential mechanisms mediated by diet : gut microbiota interactions", Curr Nutr Rep, 6, pp.315~322 (2017)
5. Foulkes WD, "Inherited susceptibility to common cancers", N Engl J Med, 359, pp.2143~2153 (2008)
6. O’Keefe SJ, "Why do African Americans get more colon cancer than Native Africans?", J Nutr, 137(1 Suppl), pp.175S~182S (2007)
7. Eaden JA, "The risk of colorectal cancer in ulcerative colitis : a meta-analysis", Gut, 48, pp.526~535 (2001)
8. Canavan C, "Meta-analysis : colorectal and small bowel cancer risk in patients with Crohn’s disease", Aliment Pharmacol Ther, 23, pp.1097~1104 (2006)
9. Caruso R, "Host-microbiota interactions in inflammatory bowel disease", Nat Rev Immunol, 20, pp.411~426 (2020)
10. Drewes JL, "Sporadic colorectal cancer : microbial contributors to disease prevention, development and therapy", Br J Cancer, 115, pp.273~280 (2016)
11. Chen W, "Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer", PLoS One, 7, pp.e39743~ (2012)
12. Rubinstein MR, "Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin", β-catenin signaling via its FadA adhesin, 2013, pp.14, 195~206
13. Brennan CA, "Gut microbiota, inflammation, and colorectal cancer", Annu Rev Microbiol, 70, pp.395~411 (2016)
14. Boleij A, "Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients : systematic review and metaanalysis", Clin Infect Dis, 53, pp.870~878 (2011)
15. Wu S, "A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses", Nat Med, 15, pp.1016~1022 (2009)
16. Cani PD, "Microbial regulation of organismal energy homeostasis", Nat Metab, 1, pp.34~46 (2019)
17. Zheng X, "The footprints of gut microbial-mammalian co-metabolism", J Proteome Res, 10, pp.5512~5522 (2011)
18. Sender R, "Revised estimates for the number of human and bacteria cells in the body", PLoS Biol, 14, pp.e1002533~ (2016)
19. Rooks MG, "Gut microbiota, metabolites and host immunity", Nat Rev Immunol, 16, pp.341~352 (2016)
20. Sun R, "Critical roles of bile acids in regulating intestinal mucosal immune responses", Therap Adv Gastroenterol, 14, pp.17562848211018098~ (2021)
21. Wishart DS, "Metabolomics : applications to food science and nutrition research", Trends Food Sci Technol, 19, pp.482~493 (2008)
22. Reddy BS, "Colon carcinogenesis in germ-free rats with 1, 2-dimethylhydrazine and N-methyl-n’-nitro-N-nitrosoguanidine", Cancer Res, 34, pp.2368~2372 (1974)
23. Reddy BS, "Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats", Cancer Res, 35, pp.287~290 (1975)
24. Donohoe DR, "The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon", Cell Metab, 13, pp.517~526 (2011)
25. Cummings JH, "Short chain fatty acids in the human colon", Gut, 22, pp.763~779 (1981)
26. Cummings JH, "The effect of meat protein and dietary fiber on colonic function and metabolism : II. Bacterial metabolites in feces and urine", Am J Clin Nutr, 32, pp.2094~2101 (1979)
27. Cummings JH, "Short chain fatty acids in human large intestine, portal, hepatic and venous blood", Gut, 28, pp.1221~1227 (1987)
28. Machiels K, "A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis", Gut, 63, pp.1275~1283 (2014)
29. den Besten G, "The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism", J Lipid Res, 54, pp.2325~2340 (2013)
30. Topping DL, "Short-chain fatty acids and human colonic function : roles of resistant starch and nonstarch polysaccharides", Physiol Rev, 81, pp.1031~1064 (2001)
31. Bergman EN, "Energy contributions of volatile fatty acids from the gastrointestinal tract in various species", Physiol Rev, 70, pp.567~590 (1990)
32. Miyauchi S, "Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids", J Biol Chem, 279, pp.13293~13296 (2004)
33. Ritzhaupt A, "Identification and characterization of a monocarboxylate transporter(MCT1)in pig and human colon : its potential to transport L-lactate as well as butyrate", J Physiol, 513(Pt 3), pp.719~732 (1998)
34. Sivaprakasam S, "Shortchain fatty acid transporters : role in colonic homeostasis", Compr Physiol, 8, pp.299~314 (2017)
35. Le Poul E, "Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation", J Biol Chem, 278, pp.25481~25489 (2003)
36. Taggart AK, "(D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G", J Biol Chem, 280, pp.26649~26652 (2005)
37. Pluznick JL, "Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation", Proc Natl Acad Sci U S A, 110, pp.4410~4415 (2013)
38. Licciardi PV, "Histone deacetylase inhibition and dietary short-chain fatty acids", ISRN Allergy, 2011, pp.869647~ (2011)
39. Park J, "Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway", Mucosal Immunol, 8, pp.80~93 (2015)
40. Lefebvre M, "Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells", J Endocrinol, 162, pp.331~340 (1999)
41. Alex S, "Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferatoractivated receptor γ", Mol Cell Biol, 33, pp.1303~1316 (2013)
42. Ma Y, "Dietary fiber intake and risks of proximal and distal colon cancers: a meta-analysis", Medicine(Baltimore), 97, pp.e11678~ (2018)
43. Kim Y, "Dietary fibre intake and mortality from cardiovascular disease and all cancers : a meta-analysis of prospective cohort studies", Arch Cardiovasc Dis, 109, pp.39~54 (2016)
44. Peters U, "Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme", Lancet, 361, pp.1491~1495 (2003)
45. Masrul M, "Dietary fibre protective against colorectal cancer patients in Asia : a meta-analysis", Open Access Maced J Med Sci, 7, pp.1723~1727 (2019)
46. Gianfredi V, "Is dietary fibre truly protective against colon cancer? A systematic review and meta-analysis", Int J Food Sci Nutr, 69, pp.904~915 (2018)
47. Le Leu RK, "Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue : a randomised clinical trial", Br J Nutr, 114, pp.220~230 (2015)
48. Borges-Canha M, "Role of colonic microbiota in colorectal carcinogenesis : a systematic review", Rev Esp Enferm Dig, 107, pp.659~671 (2015)
49. Chen HM, "Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma", Am J Clin Nutr, 97, pp.1044~1052 (2013)
50. Weir TL, "Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults", PLoS One, 8, pp.e70803~ (2013)
51. Donohoe DR, "A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota-and butyrate-dependent manner", Cancer Discov, 4, pp.1387~1397 (2014)
52. Scheppach W, "Role of short-chain fatty acids in the prevention of colorectal cancer", Eur J Cancer, 31A, pp.1077~1080 (1995)
53. Hu S, "The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer", PLoS One, 6, pp.e16221~ (2011)
54. Kim M, "Microbial metabolites, short-chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice", Eur J Immunol, 48, pp.1235~1247 (2018)
55. Thangaraju M, "GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon", Cancer Res, 69, pp.2826~2832 (2009)
56. Pan P, "Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors", Int J Cancer, 143, pp.886~896 (2018)
57. Chen D, "Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota", Cancer Lett, 469, pp.456~467 (2020)
58. Antunes KH, "Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response", Nat Commun, 10, pp.3273~ (2019)
59. Sencio V, "Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production", Cell Rep, 30, pp.2934~2947 (2020)
60. Machado MG, "Short-chain fatty acids as a potential treatment for infections : a closer look at the lungs", Infect Immun, 89, pp.e0018821~ (2021)
61. Kim M, "Gut microbial metabolites fuel host antibody responses", Cell Host Microbe, 20, pp.202~214 (2016)
62. Kim CH, "Immune regulation by microbiome metabolites", Immunology, 154, pp.220~229 (2018)
63. Singh N, "Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis", Immunity, 40, pp.128~139 (2014)
64. Zhao Y, "GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3", Mucosal Immunol, 11, pp.752~762 (2018)
65. Schauber J, "Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes : relevance of signalling pathways", Gut, 52, pp.735~741 (2003)
66. Kim MH, "Shortchain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice", Gastroenterology, 145, pp.396~406 (2013)
67. Ohira H, "Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages", J Atheroscler Thromb, 20, pp.425~442 (2013)
68. Nastasi C, "The effect of short-chain fatty acids on human monocyte-derived dendritic cells", Sci Rep, 5, pp.16148~ (2015)
69. Kim CH, "Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids", Cell Mol Immunol, 18, pp.1161~1171 (2021)
70. Sepahi A, "Dietary fiber metabolites regulate innate lymphoid cell responses", Mucosal Immunol, 14, pp.317~330 (2021)
71. Chun E, "Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity", Immunity, 51, pp.871~884 (2019)
72. Thio CL, "Regulation of type 2innate lymphoid cell-dependent airway hyperreactivity by butyrate", J Allergy Clin Immunol, 142, pp.1867~1883 (2018)
73. Vinolo MA, "SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor", PLoS One, 6, pp.e21205~ (2011)
74. Shen S, "Deficiency of dietary fiber modulates gut microbiota composition, neutrophil recruitment and worsens experimental colitis", Front Immunol, 12, pp.619366~ (2021)
75. Wu W, "Microbiota metabolite shortchain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43", Mucosal Immunol, 10, pp.946~956 (2017)
76. Arpaia N, "Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation", Nature, 504, pp.451~455 (2013)
77. Wiechers C, "The microbiota is dispensable for the early stages of peripheral regulatory T cell induction within mesenteric lymph nodes", Cell Mol Immunol, 18, pp.1211~1221 (2021)
78. Gérard P, "Metabolism of cholesterol and bile acids by the gut microbiota", Pathogens, 3, pp.14~24 (2013)
79. Ridlon JM, "Bile salt biotransformations by human intestinal bacteria", J Lipid Res, 47, pp.241~259 (2006)
80. Devlin AS, "A biosynthetic pathway for a prominent class of microbiota-derived bile acids", Nat Chem Biol, 11, pp.685~690 (2015)
81. Hamilton JP, "Human cecal bile acids : concentration and spectrum", Am J Physiol Gastrointest Liver Physiol, 293, pp.G256~G263 (2007)
82. Nguyen TT, "Role of bile acids in colon carcinogenesis", World J Clin Cases, 6, pp.577~588 (2018)
83. Copple BL, "Pharmacology of bile acid receptors : evolution of bile acids from simple detergents to complex signaling molecules", Pharmacol Res, 104, pp.9~21 (2016)
84. Yoneno K, "TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn’s disease", Immunology, 139, pp.19~29 (2013)
85. Traub RJ, "A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid", Gastroenterology, 135, pp.2075~2083 (2008)
86. Bayerdörffer E, "Increased serum deoxycholic acid levels in men with colorectal adenomas", Gastroenterology, 104, pp.145~151 (1993)
87. Kishida T, "Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects", J Gastroenterol, 32, pp.306~311 (1997)
88. Ocvirk S, "A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer", Am J Clin Nutr, 111, pp.406~419 (2020)
89. Ou J, "Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations", Nutr Cancer, 64, pp.34~40 (2012)
90. Ochsenkühn T, "Colonic mucosal proliferation is related to serum deoxycholic acid levels", Cancer, 85, pp.1664~1669 (1999)
91. Alberts DS, "Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence", J Natl Cancer Inst, 97, pp.846~853 (2005)
92. Batta AK, "Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps", Cancer Res, 58, pp.1684~1687 (1998)
93. Pearson T, "Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development", Cancer Med, 8, pp.617~628 (2019)
94. Summerton J, "Effect of deoxycholic acid on the tumour incidence, distribution, and receptor status of colorectal cancer in the rat model", Digestion, 31, pp.77~81 (1985)
95. Bernstein C, "Carcinogenicity of deoxycholate, a secondary bile acid", Arch Toxicol, 85, pp.863~871 (2011)
96. Ajouz H, "Secondary bile acids : an underrecognized cause of colon cancer", World J Surg Oncol, 12, pp.164~ (2014)
97. Pai R, "Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness", Mol Biol Cell, 15, pp.2156~2163 (2004)
98. Qiao D, "Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53protein degradation", Carcinogenesis, 22, pp.957~964 (2001)
99. Qiao D, "Activation and role of mitogen-activated protein kinases in deoxycholic acidinduced apoptosis", Carcinogenesis, 22, pp.35~41 (2001)
100. Cao W, "Expression of bile acid receptor TGR5 in gastric adenocarcinoma", Am J Physiol Gastrointest Liver Physiol, 304, pp.G322~G327 (2013)
101. Yu J, "Farnesoid X receptor antagonizes Wnt", β-catenin signaling in colorectal tumorigenesis, 2020, pp.11, 640~
102. Lax S, "Expression of the nuclear bile acid receptor", farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis, 2012, pp.130, 2232~2239
103. Milovic V, "Polyamines in the gut lumen : bioavailability and biodistribution", Eur J Gastroenterol Hepatol, 13, pp.1021~1025 (2001)
104. Tofalo R, "Polyamines and gut microbiota", Front Nutr, 6, pp.16~ (2019)
105. Matsumoto M, "The relationship between microbiota and polyamine concentration in the human intestine : a pilot study", Microbiol Immunol, 51, pp.25~35 (2007)
106. Nakajima T, "Urinary polyamine biomarker panels with machine-learning differentiated colorectal cancers, benign disease, and healthy controls", Int J Mol Sci, 19, pp.756~ (2018)
107. Elmets CA, "Targeting ornithine decarboxylase for the prevention of nonmelanoma skin cancer in humans", Cancer Prev Res(Phila), 3, pp.8~11 (2010)
108. Upp JR Jr, "Polyamine levels and gastrin receptors in colon cancers", Ann Surg, 207, pp.662~669 (1988)
109. Milovic V, "Lowdose deoxycholic acid stimulates putrescine uptake in colon cancer cells(Caco-2)", Cancer Lett, 154, pp.195~200 (2000)
110. Wallace HM, "Polyamines and colon cancer", Eur J Gastroenterol Hepatol, 13, pp.1033~1039 (2001)
111. Wang C, "Spermidine", spermine N1-acetyltransferase regulates cell growth and metastasis via AKT, Oncotarget, pp.2017, 8[DOI]
112. Li J, "Polyamines and related signaling pathways in cancer", Cancer Cell Int, 20, pp.539~ (2020)
113. Linsalata M, "Pharmacological and dietary agents for colorectal cancer chemoprevention : effects on polyamine metabolism(review)", Int J Oncol, 45, pp.1802~1812 (2014)
114. Hayes CS, "Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment", Cancer Immunol Res, 2, pp.274~285 (2014)
115. Roy UK, "Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosis", Mol Carcinog, 47, pp.538~553 (2008)
116. Alexander ET, "A novel polyamine blockade therapy activates an anti-tumor immune response", Oncotarget, 8, pp.84140~84152 (2017)
117. Hesterberg RS, "Role of polyamines in immune cell functions", Med Sci(Basel), 6, pp.22~ (2018)
118. Zhang M, "Regulation of macrophage activation and inflammation by spermine : a new chapter in an old story", Crit Care Med, 28(4 Suppl), pp.N60~N66 (2000)
119. Wyatt M, "Targeting dietary and microbial tryptophan-indole metabolism as therapeutic approaches to colon cancer", Nutrients, 13, pp.1189~ (2021)
120. Darkoh C, "A rapid and specific method for the detection of indole in complex biological samples", Appl Environ Microbiol, 81, pp.8093~8097 (2015)
121. Chappell CL, "Fecal indole as a biomarker of susceptibility to cryptosporidium infection", Infect Immun, 84, pp.2299~2306 (2016)
122. Dodd D, "A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites", Nature, 551, pp.648~652 (2017)
123. Bansal T, "The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation", Proc Natl Acad Sci U S A, 107, pp.228~233 (2010)
124. Jennis M, "Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo", Neurogastroenterol Motil, 30, pp.e13178~ (2018)
125. Busbee PB, "Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner", JCI Insight, 5, pp.e127551~ (2020)
126. Sun XZ, "Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer", World J Gastroenterol, 26, pp.7173~7190 (2020)
127. Lafita-Navarro MC, "The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells", Genes Dev, 32, pp.1303~1308 (2018)
128. Opitz CA, "An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor", Nature, 478, pp.197~203 (2011)
129. von Bubnoff D, "FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses", J Immunol, 169, pp.1810~1816 (2002)
130. Díaz-Díaz CJ, "The aryl hydrocarbon receptor is a repressor of inflammationassociated colorectal tumorigenesis in mouse", Ann Surg, 264, pp.429~436 (2016)
131. Kawajiri K, "Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in Apc-Min", + mice with natural ligands, 2009, pp.106, 13481~13486
132. Fujioka N, "Research on cruciferous vegetables, indole-3-carbinol, and cancer prevention : a tribute to Lee W. Wattenberg", Mol Nutr Food Res, 60, pp.1228~1238 (2016)
133. Andersson P, "A constitutively active dioxin", aryl hydrocarbon receptor induces stomach tumors, 2002, pp.99, 9990~9995
134. Murray IA, "Aryl hydrocarbon receptor ligands in cancer : friend and foe", Nat Rev Cancer, 14, pp.801~814 (2014)
135. Guo FF, "Emerging roles of hydrogen sulfide in inflammatory and neoplastic colonic diseases", Front Physiol, 7, pp.156~ (2016)
136. Nguyen LH, "Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men", Gastroenterology, 158, pp.1313~1325 (2020)
137. Kanazawa K, "Factors influencing the development of sigmoid colon cancer : bacteriologic and biochemical studies", Cancer, 77(8 Suppl), pp.1701~1706 (1996)
138. Ijssennagger N, "Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon", Proc Natl Acad Sci U S A, 112, pp.10038~10043 (2015)
139. Attene-Ramos MS, "Hydrogen sulfide induces direct radical-associated DNA damage", Mol Cancer Res, 5, pp.455~459 (2007)
140. Christl SU, "Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa : a potential role for these agents in the pathogenesis of ulcerative colitis", Dig Dis Sci, 41, pp.2477~2481 (1996)
141. Zhou Z, "Fusobacterium and colorectal cancer", Front Oncol, 8, pp.371~ (2018)
142. Repass J, "Replication study : Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma", Elife, 7, pp.e25801~ (2018)
143. Ternes D, "The gut microbial metabolite formate exacerbates colorectal cancer progression", Nat Metab, 4, pp.458~475 (2022)
144. Liu X, "Preoperative serum TMAO level is a new prognostic marker for colorectal cancer", Biomark Med, 11, pp.443~447 (2017)
145. Bae S, "Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study", Cancer Res, 74, pp.7442~7452 (2014)
146. Farhangi MA, "Novel findings of the association between gut microbiota-derived metabolite trimethylamine N-oxide and inflammation : results from a systematic review and dose-response meta-analysis", Crit Rev Food Sci Nutr, 60, pp.2801~2823 (2020)
147. Yue C, "Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells", Biochem Biophys Res Commun, 490, pp.541~551 (2017)
148. Li T, "Elevated circulating trimethylamine N-oxide levels contribute to endothelial dysfunction in aged rats through vascular inflammation and oxidative stress", Front Physiol, 8, pp.350~ (2017)
149. Windey K, "Relevance of protein fermentation to gut health", Mol Nutr Food Res, 56, pp.184~196 (2012)
150. Le Leu RK, "Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats", Carcinogenesis, 28, pp.240~245 (2007)
151. Fong W, "Gut microbiota modulation : a novel strategy for prevention and treatment of colorectal cancer", Oncogene, 39, pp.4925~4943 (2020)
152. Kim M, "Dietary fat intake and risk of colorectal cancer : a systematic review and meta-analysis of prospective studies", Nutrients, 10, pp.1963~ (2018)

관련 논문AI추천